Patients with IBD found to be at higher risk of lymphoma

The risk of developing lymphoma is slightly elevated in inflammatory bowel disease (IBD) and has increased in recent years in patients with Crohn’s disease, report researchers from Karolinska Institutet in a study published in Clinical Gastroenterology and Hepatology. The researchers could see a risk increase in patients taking modern IBD drugs and less so in patients not on such drugs, indicating that the lymphoma risk could be affected by both the medication and the disease activity itself.